PHILADELPHIA, Sept. 02, 2026 (GLOBE NEWSWIRE) -- CMI Media Group, a leader in precision healthcare communications and WPP company (NYSE: WPP), announces the formal launch of a specialty communications business unit. Long recognized for developing proprietary solutions that empower life sciences brands to outperform expectations, CMI Media Group has purpose-built this new unit to deliver modern, specialized communication strategies beyond traditional commercial advertising.
Central to this launch is the immediate deployment of advanced capabilities for Medical Affairs which has become biopharma’s essential “Third Pillar.” As therapeutic education begins earlier in molecule development and treatment paradigms grow more complex, CMI Media Group is already actively collaborating with multiple leading biopharma organizations to transform how scientific exchange is architected, delivered, and measured. By reshaping previously fragmented medical communications into high-value, insight-driven interactions, the unit aims to elevate scientific understanding and ultimately improve patient outcomes.
The business unit is led by proven industry innovators with decades of collective healthcare leadership. Eugene Lee, Group President, Specialty Communications, brings over 30 years of strategic media vision and industry-recognized excellence navigating life sciences' most complex communication challenges. Alongside him, Mike Reynolds, SVP, Medical and Scientific Communications, leverages a deep, trusted track record across medical affairs, market access, and data-driven HCP engagement. Together, their specialized domain expertise gives biopharma partners the trusted, senior-level leadership required to transform modern scientific exchange.
“Medical Affairs is experiencing a monumental evolution. The landscape demands a level of sophistication, omnichannel continuity, and measurement rigor that legacy models simply were not built to support,” said Lee. “We are actively building and executing the future of scientific communications right now alongside our clients. By adapting modern data, AI, and strategic frameworks specifically to the strict compliance and governance needs of Medical Affairs, we are helping biopharma leaders reshape this pillar into a strategic powerhouse.”
Through this dedicated business unit, CMI Media Group introduces core capabilities designed to meet the unique, compliant needs of scientific and medical teams:
- Compliant Omnichannel Scientific Ecosystems: Connecting Medical Science Liaison (MSL) engagement, medical congresses, peer-to-peer (P2P) education, digital non-personal channels, search, and emerging media into a unified, insight-driven ecosystem.
- Next-Generation Measurement: Moving beyond vanity effort metrics (reach, impressions, sends) to proprietary, autonomous frameworks that measure behavioral shifts, educational impact, and real-world clinical insight compliantly above the firewall.
- Cross-Functional Alignment & Synergy: Facilitating coordinated, patient-centric educational strategies that respect compliance and firewalls while breaking down organizational silos in light of evolving regulatory landscapes.
- AI-Enhanced Scientific Intelligence: Deploying ethical, purpose-built AI and advanced analytics to identify expanding community HCP audiences and trigger timely, compliant educational exchanges.
“For too long, medical communications have lacked access to the cutting-edge tools and omnichannel intelligence standard in other areas of healthcare,” added Reynolds. “Our Specialty Communications team closes that gap immediately. We are delivering true Next-Best-Action capabilities and sophisticated ROE measurement that respect compliance boundaries while giving Medical Affairs teams the strategic leverage they have earned.”
With the introduction of this dedicated unit, CMI Media Group will be focusing on critical practices spanning Medical Affairs, Scientific Communications, Rare Disease, Payer and Market Access, and Account-Based Marketing, the unit aims to bridge critical gaps across the therapeutic lifecycle to drive better-informed healthcare ecosystems.
For more information about CMI Media Group’s Specialty Communications Business Unit and its Medical Affairs practice, please visit www.cmimediagroup.com or email medicalaffairs@cmimediagroup.com.
About CMI Media Group
CMI Media Group, a WPP company (NYSE: WPP, http://www.wpp.com), is a global, full-service media agency focused solely on health, wellness, pharmaceutical marketing and medical communication. CMI Media Group’s core offerings include Audience Strategy, Planning, Development, and Insights; Data and Analytics; Buying and Investment; and Direct Response and Customer Experience. As the leading media resource for the world’s top healthcare companies, CMI Media Group brings together leading technology, data, and talent to deliver seamless capabilities for clients. CMI Media Group is part of WPP, the trusted growth partner for the world's leading brands and therapies. Powered by exceptional talent and our agentic marketing platform WPP Open, WPP unites cutting-edge media intelligence and data solutions, creativity, production, enterprise solutions and expert strategic counsel. CMI Media Group has been recognized as a leader in inclusivity, talent retention and employee development as well as one of the industry’s best places to work. To apply for a position within our teams visit https://www.cmimediagroup.com/careers/
Press contact:
Carly Kuper
610-731-5409
ckuper@cmimediagroup.com
